CompoAtlas

Calcium

Natural health product licensed in Canada

Licence holder
Yisroel Goldstein
NPN or DIN-HM
80070161
Status
Inactive licence
Licence date
9 June 2016
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Calcium

Source : Calcium

1,000 milligramme4,000,000 µg
Vitamine D

Source : Cholécalciférol

1,000 UI100 µg

Non-medicinal ingredients

Silice, Stéarate de magnésium, Cellulose microcristalline

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 1 Comprimé ; maximum: 2 Compriméminimum: 1 day ; maximum: 2 days
AdolescentsNot specifiedminimum: 1 Comprimé ; maximum: 2 Compriméminimum: 1 day ; maximum: 2 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Daily use as A factor in the maintenance of good health. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may help prevent bone loss/osteoporosis (in peri- and postmenopausal women) (in later life). Helps in the development and maintenance of bones and teeth especially in childhood, adolescence and young adulthood.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80070161

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line